Assessment of cognitive symptoms in Brain Bank-registered control subjects: feasibility and utility of a telephone-based screening

Manuscript Number: 

21-5444R1

Author(s): 
Iban Aldecoa, Mircea Balasa, Yaroslau Compta, Ellen Gelpi, Gerard Mayà, Laura Molina-Porcel, Jordi Sarto, Raquel Sánchez-Valle, Teresa Ximelis

Disclosures

Iban Aldecoa

  • Nothing to Disclose

Mircea Balasa

  • Nothing to Disclose

Yaroslau Compta

  • Nothing to Disclose

Ellen Gelpi

  • Nothing to Disclose

Gerard Mayà

  • Nothing to Disclose

Laura Molina-Porcel

  • Nothing to Disclose

Raquel Sánchez-Valle

  • Consulting Fees:
    Dr. Raquel Sanchez-Valle reports personal fees from Wave pharmaceuticals and Ionis Pharmaceuticals for attending Advisory board meetings, personal fees from Roche diagnostics, Janssen and Neuraxpharm for educational activities, and research grants to her institution from Biogen and Sage Therapeutics outside the submitted work.

Jordi Sarto

  • Nothing to Disclose

Teresa Ximelis

  • Nothing to Disclose